Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

November 16, 2020 Issue

09844-cover1-webopener.jpg

November 16, 2020 Cover

Volume 98, Issue 44

Nothing stops these chemistry entrepreneurs from working toward a better future

Cover image:Nothing stops these entrepreneurs from working toward a better future

Credit: Matt Chinworth Illustration

Full Article
Volume 98 | Issue 44

All Issues

Start-ups

C&EN’s 2020 10 Start-Ups to Watch

Nothing stops these chemistry entrepreneurs from working toward a better future

  • Biden-Harris priorities include areas important to chemists and chemistry

    Revised policies aim to control the coronavirus, recover the economy, address inequity, and combat climate change

  • Pfizer and BioNTech say their COVID-19 vaccine is successful in late-stage trial

    A preliminary analysis of the 43,500-person study found the firms’ jointly developed mRNA vaccine 90% effective compared with placebo

  • Road to chiral alkylamines paved with iridium

    Cationic catalyst adds amines to internal alkenes

ADVERTISEMENT
image name
Global Health

Biden-Harris priorities include areas important to chemists and chemistry

Revised policies aim to control the coronavirus, recover the economy, address inequity, and combat climate change

ADVERTISEMENT
ADVERTISEMENT